| Primary |
| Drug Abuse |
22.2% |
| Analgesic Therapy |
11.1% |
| Chronic Obstructive Pulmonary Disease |
8.9% |
| General Anaesthesia |
8.9% |
| Hypertension |
8.9% |
| Sedation |
8.9% |
| Hiv Infection |
4.4% |
| Intentional Drug Misuse |
4.4% |
| Nausea |
4.4% |
| Anaesthesia |
2.2% |
| Colonoscopy |
2.2% |
| Coronary Artery Disease |
2.2% |
| Induction Of Anaesthesia |
2.2% |
| Product Used For Unknown Indication |
2.2% |
| Sedative Therapy |
2.2% |
| Substance Use |
2.2% |
| Type 2 Diabetes Mellitus |
2.2% |
|
| Suicidal Ideation |
11.5% |
| Ureteric Stenosis |
11.5% |
| Liver Function Test Abnormal |
7.7% |
| Waxy Flexibility |
7.7% |
| Cardiac Arrest |
3.8% |
| Drug Abuse |
3.8% |
| Drug Dependence |
3.8% |
| Dysuria |
3.8% |
| Laryngospasm |
3.8% |
| Lower Urinary Tract Symptoms |
3.8% |
| Medication Error |
3.8% |
| Nervous System Disorder |
3.8% |
| Platelet Aggregation Inhibition |
3.8% |
| Pollakiuria |
3.8% |
| Pulseless Electrical Activity |
3.8% |
| Reduced Bladder Capacity |
3.8% |
| Renal Infarct |
3.8% |
| Respiratory Depression |
3.8% |
| Substance Use |
3.8% |
| Supraventricular Tachycardia |
3.8% |
|
| Secondary |
| Product Used For Unknown Indication |
27.1% |
| Drug Abuse |
12.2% |
| Drug Use For Unknown Indication |
10.5% |
| Electrolyte Substitution Therapy |
7.8% |
| Pain |
7.0% |
| Anaesthesia |
5.0% |
| Stupor |
4.3% |
| Arthritis |
3.7% |
| Premedication |
3.3% |
| Hypertension |
2.8% |
| Restlessness |
2.1% |
| Foetal Exposure During Pregnancy |
2.1% |
| Maternal Exposure Timing Unspecified |
2.1% |
| General Anaesthesia |
2.0% |
| Drug Exposure Via Mother |
1.4% |
| Hypothyroidism |
1.4% |
| Constipation |
1.4% |
| Induction Of Anaesthesia |
1.3% |
| Hypotension |
1.3% |
| Depression |
1.2% |
|
| Renal Failure Acute |
14.8% |
| Toxic Epidermal Necrolysis |
12.5% |
| Stevens-johnson Syndrome |
9.4% |
| Hepatocellular Injury |
6.3% |
| Toxicity To Various Agents |
6.3% |
| Premature Baby |
5.5% |
| Toxic Skin Eruption |
5.5% |
| Drug Ineffective |
4.7% |
| Shock |
4.7% |
| Anaphylactic Shock |
3.9% |
| Drug Abuse |
3.1% |
| Foetal Growth Restriction |
3.1% |
| Maternal Exposure Timing Unspecified |
3.1% |
| Sedation |
3.1% |
| Vomiting |
3.1% |
| Pancreatitis Acute |
2.3% |
| Pyrexia |
2.3% |
| Respiratory Failure |
2.3% |
| Tachycardia |
2.3% |
| Bacterial Infection |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.7% |
| Drug Use For Unknown Indication |
19.6% |
| Sedation |
9.9% |
| Status Epilepticus |
7.6% |
| Pain |
7.3% |
| Acute Lymphocytic Leukaemia |
5.5% |
| Analgesic Therapy |
4.9% |
| Infection |
2.1% |
| Pneumonia |
2.1% |
| Haemodynamic Instability |
2.0% |
| Prophylaxis |
1.8% |
| Rhabdomyosarcoma |
1.8% |
| Nausea |
1.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.5% |
| Anaesthesia |
1.5% |
| Constipation |
1.5% |
| Induction Of Anaesthesia |
1.4% |
| Intestinal Adhesion Lysis |
1.4% |
| Medical Diet |
1.4% |
| Positive Cardiac Inotropic Effect |
1.4% |
|
| Rhabdomyolysis |
11.9% |
| Tumour Haemorrhage |
10.7% |
| Rectal Haemorrhage |
7.1% |
| Tachycardia |
7.1% |
| Mucosal Inflammation |
6.0% |
| Pneumonia |
6.0% |
| Thrombocytopenia |
6.0% |
| Haematemesis |
4.8% |
| Lymphoma |
4.8% |
| Off Label Use |
4.8% |
| Tooth Disorder |
4.8% |
| Pulseless Electrical Activity |
3.6% |
| Status Epilepticus |
3.6% |
| Suicidal Ideation |
3.6% |
| Type Iv Hypersensitivity Reaction |
3.6% |
| Back Pain |
2.4% |
| Cardiac Arrest |
2.4% |
| Death |
2.4% |
| Deep Vein Thrombosis |
2.4% |
| Hyperhidrosis |
2.4% |
|
| Interacting |
| Abdominal Pain |
16.8% |
| Restlessness |
16.8% |
| Spinal Anaesthesia |
11.2% |
| Cancer Pain |
8.0% |
| Product Used For Unknown Indication |
8.0% |
| Sedative Therapy |
7.2% |
| Antibiotic Prophylaxis |
5.6% |
| Local Anaesthesia |
4.8% |
| Pain |
4.8% |
| Adrenal Insufficiency |
1.6% |
| Anaesthesia Procedure |
1.6% |
| Anxiety |
1.6% |
| Caesarean Section |
1.6% |
| Induction Of Anaesthesia |
1.6% |
| Paralysis |
1.6% |
| Pneumonia |
1.6% |
| Pneumonia Fungal |
1.6% |
| Pneumonitis |
1.6% |
| Renal Cancer Metastatic |
1.6% |
| Anaesthesia |
0.8% |
|
| Myoclonus |
44.4% |
| Drug Interaction |
11.1% |
| Electromechanical Dissociation |
11.1% |
| Somnolence |
11.1% |
| Suicidal Ideation |
11.1% |
| Toxicity To Various Agents |
5.6% |
| Trichotillomania |
5.6% |
|
